ResMed Inc. (RMD): A Bull Case Theory 

We came across a bullish thesis on ResMed Inc. on Best Anchor Stocks’s Substack. In this article, we will summarize the bulls’ thesis on RMD. ResMed Inc.’s share was trading at $257.61 as of January 29th. RMD’s trailing and forward P/E were 26.38 and 23.70 respectively according to Yahoo Finance.

Veeva Expands Basics Suite as Over 100 Biotechs Adopt Platform for Scalable Growth

everything possible/Shutterstock.com

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage...